Structure-based protein-protein interaction networks and drug design
暂无分享,去创建一个
[1] A. Barabasi,et al. Functional and topological characterization of protein interaction networks , 2004, Proteomics.
[2] J. J. Walsh,et al. Tubulin-targeting agents in hybrid drugs. , 2010, Current medicinal chemistry.
[3] David Warde-Farley,et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.
[4] Raymond K. Auerbach,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[5] M. Vidal,et al. Literature-curated protein interaction , 2009 .
[6] M. Eisenstein,et al. Peptide inhibitors targeting protein kinases. , 2009, Current pharmaceutical design.
[7] Rohita Sinha,et al. Docking by structural similarity at protein‐protein interfaces , 2010, Proteins.
[8] T. Herrmann,et al. Advances in automated NMR protein structure determination , 2011, Quarterly Reviews of Biophysics.
[9] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[10] D. Levitt,et al. POCKET: a computer graphics method for identifying and displaying protein cavities and their surrounding amino acids. , 1992, Journal of molecular graphics.
[11] Jing Yang,et al. The human disease network in terms of dysfunctional regulatory mechanisms , 2015, Biology Direct.
[12] Ruth Nussinov,et al. PatchDock and SymmDock: servers for rigid and symmetric docking , 2005, Nucleic Acids Res..
[13] Ioannis Xenarios,et al. DIP: The Database of Interacting Proteins: 2001 update , 2001, Nucleic Acids Res..
[14] Gerhard Klebe,et al. An old target revisited: two new privileged skeletons and an unexpected binding mode for HIV-protease inhibitors. , 2005, Angewandte Chemie.
[15] Susumu Goto,et al. KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..
[16] Michael J. E. Sternberg,et al. The 4th meeting on the Critical Assessment of Predicted Interaction (CAPRI) held at the Mare Nostrum, Barcelona , 2010 .
[17] V. Helms,et al. Transient pockets on protein surfaces involved in protein-protein interaction. , 2007, Journal of medicinal chemistry.
[18] R. Sharan,et al. A systems-level approach to mapping the telomere length maintenance gene circuitry , 2008, Molecular systems biology.
[19] R. Nussinov,et al. Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM , 2011, Nature Protocols.
[20] E. Major. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. , 2010, Annual review of medicine.
[21] Emil Alexov,et al. omology-based modeling of 3 D structures of protein – protein complexes using lignments of modified sequence profiles etras , 2008 .
[22] Joel S. Bader,et al. Where Have All the Interactions Gone? Estimating the Coverage of Two-Hybrid Protein Interaction Maps , 2007, PLoS Comput. Biol..
[23] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[24] G. Schneider,et al. Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation , 2009, Proceedings of the National Academy of Sciences.
[25] A. Barabasi,et al. A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration , 2006, Cell.
[26] Hammad Naveed,et al. Improving the resistance of a eukaryotic β-barrel protein to thermal and chemical perturbations. , 2011, Journal of molecular biology.
[27] Rafael C. Jimenez,et al. The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..
[28] Andrew J. Bordner,et al. Predicting protein-protein binding sites in membrane proteins , 2009, BMC Bioinformatics.
[29] E. De Clercq. Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era. , 2012, Biochemical pharmacology.
[30] Philip E. Bourne,et al. PROMISCUOUS: a database for network-based drug-repositioning , 2010, Nucleic Acids Res..
[31] J. Arrowsmith. Trial watch: Phase III and submission failures: 2007–2010 , 2011, Nature Reviews Drug Discovery.
[32] G. Müller,et al. Medicinal chemistry of target family-directed masterkeys. , 2003, Drug discovery today.
[33] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[34] S. Shen-Orr,et al. Network motifs in the transcriptional regulation network of Escherichia coli , 2002, Nature Genetics.
[35] Lei Xie,et al. Structure-based systems biology for analyzing off-target binding. , 2011, Current opinion in structural biology.
[36] S. Shen-Orr,et al. Networks Network Motifs : Simple Building Blocks of Complex , 2002 .
[37] Mark A. Ragan,et al. BMC Systems Biology BioMed Central Research article Protein-protein interaction as a predictor of subcellular location , 2008 .
[38] Hongyu Zhao,et al. Is Subcellular Localization Informative for Modeling Protein-Protein Interaction Signal? , 2008, J. Electr. Comput. Eng..
[39] Paul A. Bates,et al. Global topological features of cancer proteins in the human interactome , 2006, Bioinform..
[40] Jae-Seong Yang,et al. Evolutionary conservation in multiple faces of protein interaction , 2009, Proteins.
[41] A. Bateman,et al. Protein interactions in human genetic diseases , 2008, Genome Biology.
[42] C. Ingles,et al. Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2 , 2003, Oncogene.
[43] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[44] G. Klebe,et al. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. , 2004, Journal of medicinal chemistry.
[45] Peter D. Karp,et al. The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases , 2007, Nucleic Acids Res..
[46] María J. Vicent,et al. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. , 2009, Advanced drug delivery reviews.
[47] Robert B. Russell,et al. InterPreTS: protein Interaction Prediction through Tertiary Structure , 2003, Bioinform..
[48] Joel Dudley,et al. Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..
[49] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[50] S. Rajkumar,et al. Thalidomide: tragic past and promising future. , 2004, Mayo Clinic proceedings.
[51] L. Xiangjun,et al. ? Higher Education Press and Springer-Verlag 2007 , 2007 .
[52] J. Goodrich,et al. Protein-protein interaction assays: eliminating false positive interactions , 2006, Nature Methods.
[53] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[54] Haiyuan Yu,et al. Three-dimensional reconstruction of protein networks provides insight into human genetic disease , 2012, Nature Biotechnology.
[55] Eileen Kraemer,et al. GiardiaDB and TrichDB: integrated genomic resources for the eukaryotic protist pathogens Giardia lamblia and Trichomonas vaginalis , 2008, Nucleic Acids Res..
[56] Stephen R Comeau,et al. Achieving reliability and high accuracy in automated protein docking: Cluspro, PIPER, SDU, and stability analysis in CAPRI rounds 13–19 , 2010, Proteins.
[57] Burkhard Rost,et al. Physical protein–protein interactions predicted from microarrays , 2008, Bioinform..
[58] R. Solé,et al. The topology of drug-target interaction networks: implicit dependence on drug properties and target families. , 2009, Molecular bioSystems.
[59] Hammad Naveed,et al. TMBB-Explorer: A Webserver to Predict the Structure, Oligomerization State, Ppi Interface, and Thermodynamic Properties of the Transmembrane Domains of Outer Membrane Proteins , 2012 .
[60] Randall C Willis,et al. Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). , 2006, Current protocols in bioinformatics.
[61] J. Arrowsmith. Trial watch: Phase II failures: 2008–2010 , 2011, Nature Reviews Drug Discovery.
[62] Mary K Joseph,et al. Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL. , 2007, Journal of medicinal chemistry.
[63] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[64] J. Hopfield,et al. From molecular to modular cell biology , 1999, Nature.
[65] A. Bonvin,et al. The HADDOCK web server for data-driven biomolecular docking , 2010, Nature Protocols.
[66] R. Ozawa,et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[67] Mahdi Sarmady,et al. HIV Protein Sequence Hotspots for Crosstalk with Host Hub Proteins , 2011, PloS one.
[68] Y. Ruan,et al. ChIP‐based methods for the identification of long‐range chromatin interactions , 2009, Journal of cellular biochemistry.
[69] Babak Nadjar Araabi,et al. Features analysis for identification of date and party hubs in protein interaction network of Saccharomyces Cerevisiae , 2010, BMC Systems Biology.
[70] V. Nizet,et al. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. , 2008, Science.
[71] Benjamin A. Shoemaker,et al. IBIS (Inferred Biomolecular Interaction Server) reports, predicts and integrates multiple types of conserved interactions for proteins , 2011, Nucleic Acids Res..
[72] Christie S. Chang,et al. The BioGRID interaction database: 2013 update , 2012, Nucleic Acids Res..
[73] Sean Ekins,et al. In silico repositioning of approved drugs for rare and neglected diseases. , 2011, Drug discovery today.
[74] A. Gavezzotti,et al. Molecular recognition in organic crystals: directed intermolecular bonds or nonlocalized bonding? , 2005, Angewandte Chemie.
[75] S. L. Wong,et al. Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.
[76] Pieter F. W. Stouten,et al. Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..
[77] Jie Liang,et al. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues , 2006, Nucleic Acids Res..
[78] M. Vidal,et al. Literature-curated protein interaction datasets , 2009, Nature Methods.
[79] Kara Dolinski,et al. The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..
[80] Z. Weng,et al. ZDOCK: An initial‐stage protein‐docking algorithm , 2003, Proteins.
[81] Sandhya Rani,et al. Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..
[82] J. Delaney. Finding and filling protein cavities using cellular logic operations. , 1992, Journal of molecular graphics.
[83] Lan V. Zhang,et al. Evidence for dynamically organized modularity in the yeast protein–protein interaction network , 2004, Nature.
[84] Marc S. Cortese,et al. Flexible nets , 2005, The FEBS journal.
[85] S. L. Wong,et al. A Map of the Interactome Network of the Metazoan C. elegans , 2004, Science.
[86] Livia Perfetto,et al. MINT, the molecular interaction database: 2009 update , 2009, Nucleic Acids Res..
[87] Anna R. Panchenko,et al. Homology Inference of Protein-Protein Interactions via Conserved Binding Sites , 2012, PloS one.
[88] Eric J Kunkel,et al. Systems biology in drug discovery. , 2006, Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference.
[89] R. Glaeser,et al. Reaching the information limit in cryo-EM of biological macromolecules: experimental aspects. , 2011, Biophysical journal.
[90] Cheng Zhu,et al. Drug repositioning for orphan diseases , 2011, Briefings Bioinform..
[91] Hammad Naveed,et al. Structure-based Analysis of VDAC1 Protein , 2011, The Journal of Biological Chemistry.
[92] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[93] S. Shen-Orr,et al. Network motifs: simple building blocks of complex networks. , 2002, Science.
[94] Stephen R. Comeau,et al. PIPER: An FFT‐based protein docking program with pairwise potentials , 2006, Proteins.
[95] Jie Liang,et al. Accuracy of functional surfaces on comparatively modeled protein structures , 2011, Journal of Structural and Functional Genomics.
[96] Hongkang Mei,et al. Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network , 2013, PLoS Comput. Biol..
[97] Hammad Naveed,et al. Predicting weakly stable regions, oligomerization state, and protein–protein interfaces in transmembrane domains of outer membrane proteins , 2009, Proceedings of the National Academy of Sciences.
[98] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[99] R Abagyan,et al. Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs , 2007, Proceedings of the National Academy of Sciences.
[100] N. Chandra,et al. Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance , 2008, BMC Microbiology.
[101] Hunter B. Fraser,et al. Modularity and evolutionary constraint on proteins , 2005, Nature Genetics.
[102] J. Whisstock,et al. Prediction of protein function from protein sequence and structure , 2003, Quarterly Reviews of Biophysics.
[103] Ozlem Keskin,et al. PRISM: protein interactions by structural matching , 2005, Nucleic Acids Res..
[104] M. Vidal,et al. Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". , 2001, Genome research.
[105] A. Barabasi,et al. Lethality and centrality in protein networks , 2001, Nature.
[106] Hammad Naveed,et al. Engineered oligomerization state of OmpF protein through computational design decouples oligomer dissociation from unfolding. , 2012, Journal of molecular biology.
[107] Ivica Letunic,et al. metaTIGER: a metabolic evolution resource , 2008, Nucleic Acids Res..
[108] J. Andrew McCammon,et al. Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei , 2008, Proceedings of the National Academy of Sciences.
[109] Philip E. Bourne,et al. Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model , 2010, PLoS Comput. Biol..
[110] Dennis P Wall,et al. A simple dependence between protein evolution rate and the number of protein-protein interactions , 2003, BMC Evolutionary Biology.
[111] Sean R. Collins,et al. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae , 2006, Nature.
[112] Solomon Nwaka,et al. Innovative lead discovery strategies for tropical diseases , 2006, Nature Reviews Drug Discovery.
[113] James R. Knight,et al. A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.
[114] P. Bork,et al. Proteome survey reveals modularity of the yeast cell machinery , 2006, Nature.
[115] Andreas Hoppe,et al. Docking without docking: ISEARCH—prediction of interactions using known interfaces , 2007, Proteins.
[116] Thomas Lengauer,et al. Hierarchical Bayes Model for Predicting Effectiveness of HIV Combination Therapies , 2012, Statistical applications in genetics and molecular biology.
[117] Peter Uetz,et al. Analysis of protein-protein interactions using high-throughput yeast two-hybrid screens. , 2011, Methods in molecular biology.
[118] Bin Chen,et al. Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data , 2010, BMC Bioinformatics.
[119] Patrick Aloy,et al. Interrogating protein interaction networks through structural biology , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[120] R. Sharan,et al. Protein networks in disease. , 2008, Genome research.
[121] Shinichiro Wachi,et al. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues , 2005, Bioinform..
[122] Vladimir N. Uversky,et al. The roles of intrinsic disorder in protein interaction networks , 2013 .
[123] César A. Hidalgo,et al. Scale-free networks , 2008, Scholarpedia.
[124] Peter D. Karp,et al. EcoCyc: fusing model organism databases with systems biology , 2012, Nucleic Acids Res..
[125] Nir London,et al. Can self‐inhibitory peptides be derived from the interfaces of globular protein–protein interactions? , 2010, Proteins.
[126] A. Ayhan,et al. Emerging drugs in endometrial cancers , 2010, Expert opinion on emerging drugs.
[127] R. Albert,et al. The large-scale organization of metabolic networks , 2000, Nature.
[128] Jonathan Qiang Jiang,et al. Predicting multiplex subcellular localization of proteins using protein-protein interaction network: a comparative study , 2012, BMC Bioinformatics.
[129] Eric Ennifar,et al. X-ray crystallography as a tool for mechanism-of-action studies and drug discovery. , 2013, Current pharmaceutical biotechnology.
[130] S. Rees,et al. Principles of early drug discovery , 2011, British journal of pharmacology.
[131] Bruce L. Booth,et al. Quest for the best , 2003, Nature Reviews Drug Discovery.
[132] Sergey Lyskov,et al. The RosettaDock server for local protein–protein docking , 2008, Nucleic Acids Res..
[133] B. Honig,et al. Structure-based prediction of protein-protein interactions on a genome-wide scale , 2012, Nature.
[134] Ozlem Keskin,et al. Constructing structural networks of signaling pathways on the proteome scale. , 2012, Current opinion in structural biology.
[135] Adam J. Smith,et al. The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..
[136] Ker-Chau Li,et al. Patterns of co-expression for protein complexes by size in Saccharomyces cerevisiae , 2008, Nucleic acids research.
[137] Thomas J. Begley,et al. Global network analysis of phenotypic effects: Protein networks and toxicity modulation in Saccharomyces cerevisiae , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[138] Patrick Aloy,et al. Recycling side-effects into clinical markers for drug repositioning , 2012, Genome Medicine.
[139] D. Tatro. Drug Interaction Facts , 1990 .